IL2 and metabolic dysfunction-associated steatotic liver disease: IL-2, a cytokine playing a pivotal role during chronic HCV infection, was virtually absent in NAFLD and highly expressed in HCV (Figure 3b,d); surprisingly, patients with steatohepatitis (NASH) showed an expression level comparable to that of HCV patients (Figure 3d).